Literature DB >> 17025241

Vacuum foam drying for preservation of LaSota virus: effect of additives.

Sambhaji Pisal1, Gopal Wawde, Shailendra Salvankar, Sanjay Lade, Shivajirao Kadam.   

Abstract

The purpose of this research was to apply vacuum foam drying (VFD) for processing of LaSota virus and to screen formulation additives for its stability. The aqueous dispersion of harvest containing sucrose or trehalose in combination with additive (monosaccharides, polymers, N-Z-amine) was prepared. The diluted dispersions in vials were vacuum concentrated, foamed to form a continuous structure, and vacuum dried. The products were evaluated for foam characteristics, residual moisture, virus titer, x-ray diffraction pattern, and stability profile. The foamability increased with solid content in solutions. The foamability of sucrose was enhanced with incorporation of N-Z-amine (10% and 15% wt/vol) and polyvinyl pyrrolidone (PVP K30, 3% wt/vol). The fructose- or galactose-containing mixtures were deposited irregularly on the vial surface. The virus titer increased with disaccharides in the formulation. Sucrose provided better protection than trehalose. Unlike lyophilization, N-Z-amine with sucrose protected the virus from Millard's Browning. Amino acids do not have a catalytic effect on hydrolysis of sucrose during VFD. Monosaccharides were ineffective. A synergistic effect of PVP K30 or polyethylene glycol 6000 (3% wt/vol) with N-Z-amine provided the maximum virus titer (6.97 and 7.15, respectively). This formulation retained the desired virus potency at 5 degrees , 25 degrees , and 40 degrees C. The diffraction pattern revealed that a threshold concentration of N-Z-amine was required for inhibiting crystallization of sucrose during VFD. VFD was successfully applied to produce a solid LaSota formulation. The products were amorphous and did not devitrify on storage.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17025241      PMCID: PMC2750502          DOI: 10.1208/pt070360

Source DB:  PubMed          Journal:  AAPS PharmSciTech        ISSN: 1530-9932            Impact factor:   3.246


  13 in total

Review 1.  Factors affecting short-term and long-term stabilities of proteins.

Authors:  T Arakawa; S J Prestrelski; W C Kenney; J F Carpenter
Journal:  Adv Drug Deliv Rev       Date:  2001-03-01       Impact factor: 15.470

Review 2.  Lyophilization and development of solid protein pharmaceuticals.

Authors:  W Wang
Journal:  Int J Pharm       Date:  2000-08-10       Impact factor: 5.875

Review 3.  Pharmaceutics of protein drugs.

Authors:  R Pearlman; T Nguyen
Journal:  J Pharm Pharmacol       Date:  1992-02       Impact factor: 3.765

Review 4.  Stabilization of rinderpest vaccine by modification of the lyophilization process.

Authors:  J A House; J C Mariner
Journal:  Dev Biol Stand       Date:  1996

5.  The physical state of mannitol after freeze-drying: effects of mannitol concentration, freezing rate, and a noncrystallizing cosolute.

Authors:  A I Kim; M J Akers; S L Nail
Journal:  J Pharm Sci       Date:  1998-08       Impact factor: 3.534

6.  Freeze-thaw studies of a model protein, lactate dehydrogenase, in the presence of cryoprotectants.

Authors:  S Nema; K E Avis
Journal:  J Parenter Sci Technol       Date:  1993 Mar-Apr

7.  Polymers protect lactate dehydrogenase during freeze-drying by inhibiting dissociation in the frozen state.

Authors:  T J Anchordoquy; J F Carpenter
Journal:  Arch Biochem Biophys       Date:  1996-08-15       Impact factor: 4.013

8.  Effects of Tween 80 and sucrose on acute short-term stability and long-term storage at -20 degrees C of a recombinant hemoglobin.

Authors:  B A Kerwin; M C Heller; S H Levin; T W Randolph
Journal:  J Pharm Sci       Date:  1998-09       Impact factor: 3.534

9.  Effects of polyethylene glycol molecular weight and concentration on lactate dehydrogenase activity in solution and after freeze-thawing.

Authors:  Yanli Mi; George Wood; Laura Thoma; Sahar Rashed
Journal:  PDA J Pharm Sci Technol       Date:  2002 May-Jun

10.  The influence of sucrose, dextran, and hydroxypropyl-beta-cyclodextrin as lyoprotectants for a freeze-dried mouse IgG2a monoclonal antibody (MN12).

Authors:  M E Ressing; W Jiskoot; H Talsma; C W van Ingen; E C Beuvery; D J Crommelin
Journal:  Pharm Res       Date:  1992-02       Impact factor: 4.200

View more
  5 in total

Review 1.  Advanced protein formulations.

Authors:  Wei Wang
Journal:  Protein Sci       Date:  2015-05-01       Impact factor: 6.725

2.  A method of lyophilizing vaccines containing aluminum salts into a dry powder without causing particle aggregation or decreasing the immunogenicity following reconstitution.

Authors:  Xinran Li; Sachin G Thakkar; Tinashe B Ruwona; Robert O Williams; Zhengrong Cui
Journal:  J Control Release       Date:  2015-02-28       Impact factor: 9.776

3.  The immunogenicity of thin-film freeze-dried, aluminum salt-adjuvanted vaccine when exposed to different temperatures.

Authors:  Sachin G Thakkar; Tinashe B Ruwona; Robert O Williams; Zhengrong Cui
Journal:  Hum Vaccin Immunother       Date:  2017-01-04       Impact factor: 3.452

4.  Vaccine Quality Is a Key Factor to Determine Thermal Stability of Commercial Newcastle Disease (ND)Vaccines.

Authors:  Nabila Osman; Danny Goovaerts; Serageldeen Sultan; Jeremy Salt; Christian Grund
Journal:  Vaccines (Basel)       Date:  2021-04-09

5.  Vacuum foam drying: an alternative to lyophilization for biomolecule preservation.

Authors:  R D Jangle; S S Pisal
Journal:  Indian J Pharm Sci       Date:  2012-03       Impact factor: 0.975

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.